Study on the safety and efficacy of new crown vaccine in patients with chronic liver disease

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100049657

Enrollment

Unknown

Registered

2021-08-07

Start date

2021-07-31

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic liver disease

Interventions

Chronic liver disease group:COVID-19 vaccine

Healthy control group:COVID-19 vaccine

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Healthy control group: no history of hepatitis, no history of liver cirrhosis, no history of liver cancer; received full-course vaccination against COVID-19. 2. Patients with chronic liver disease: patients with chronic liver disease diagnosed clinically or pathologically; receive full-course COVID-19 vaccination.

Exclusion criteria

Exclusion criteria: Previous laboratory-confirmed new crown, a history of contact with a confirmed new crown case, and contraindications to vaccination.

Design outcomes

Primary

Measure	Time frame
anti-SARS-CoV-2 antibody;SARS-CoV-2-specific memory B cell;liver function;	—

Countries

China

Contacts

Public ContactRen Hong

Chongqing Medical University

renhong0531@cqmu.edu.cn+86 23 63693029

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026